These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2499343)

  • 1. Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions.
    Aldaz CM; Trono D; Larcher F; Slaga TJ; Conti CJ
    Mol Carcinog; 1989; 2(1):22-6. PubMed ID: 2499343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic analysis of malignant skin tumors induced in chemically treated TG-AC transgenic mice.
    French JE; Libbus BL; Hansen L; Spalding J; Tice RR; Mahler J; Tennant RW
    Mol Carcinog; 1994 Dec; 11(4):215-26. PubMed ID: 7999263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors.
    Nelson MA; Futscher BW; Kinsella T; Wymer J; Bowden GT
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6398-402. PubMed ID: 1352887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
    Stern MC; Conti CJ
    Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
    [No Abstract]   [Full Text] [Related]  

  • 5. Overlapping loss of heterozygosity by mitotic recombination on mouse chromosome 7F1-ter in skin carcinogenesis.
    Bianchi AB; Navone NM; Aldaz CM; Conti CJ
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7590-4. PubMed ID: 1909026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors.
    Bianchi AB; Aldaz CM; Conti CJ
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6902-6. PubMed ID: 1697691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.
    Gimenez-Conti IB; Bianchi AB; Fischer SM; Reiners JJ; Conti CJ; Slaga TJ
    Cancer Res; 1992 Jun; 52(12):3432-5. PubMed ID: 1375869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-melanoma skin cancer in mouse and man.
    Schwarz M; Münzel PA; Braeuning A
    Arch Toxicol; 2013 May; 87(5):783-98. PubMed ID: 23266722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The premalignant nature of mouse skin papillomas: histopathologic, cytogenetic, and biochemical evidence.
    Aldaz CM; Conti CJ
    Carcinog Compr Surv; 1989; 11():227-42. PubMed ID: 2465820
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
    La E; Muga SJ; Locniskar MF; Fischer SM
    Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy.
    Aldaz CM; Conti CJ; Klein-Szanto AJ; Slaga TJ
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2029-32. PubMed ID: 3104907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
    Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
    Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ras activation during epidermal carcinogenesis in vitro and in vivo.
    Quintanilla M; Haddow S; Jonas D; Jaffe D; Bowden GT; Balmain A
    Carcinogenesis; 1991 Oct; 12(10):1875-81. PubMed ID: 1934268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal papillomas and carcinomas induced in uninitiated mouse skin by tumor promoters alone contain a point mutation in the 61st codon of the Ha-ras oncogene.
    Pelling JC; Neades R; Strawhecker J
    Carcinogenesis; 1988 Apr; 9(4):665-7. PubMed ID: 3128410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin.
    Hennings H
    Basic Life Sci; 1991; 57():31-9; discussion 39-42. PubMed ID: 1814291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of codon 61 Ha-ras mutations and lack of keratin 13 expression in 7,12-dimethylbenz[a]-anthracene-induced hamster skin tumors.
    Robles AI; Gimenez-Conti IB; Roop D; Slaga TJ; Conti CJ
    Mol Carcinog; 1993; 7(2):94-8. PubMed ID: 7681292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of mutated Ha-ras during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML; LaCava M; Bolontrade MF; Russell J; Conti CJ
    Mol Carcinog; 1999 Nov; 26(3):150-6. PubMed ID: 10559789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p53 gene mutations in mouse skin tumors induced by DMBA-TPA-MNNG].
    Zhang S; Guo ; Klein-Szanto A
    Zhonghua Bing Li Xue Za Zhi; 1998 Aug; 27(4):298-300. PubMed ID: 11245002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.